[Editor's note: This article was updated June 14 to mention Sciex's 2017 de novo classification for its mass spectrometry vitamin D assay as the original proposal to exempt that device category.]
US FDA finalized 510(k) exemptions for five class II device categories June 1, including a novel sponsor-by-sponsor exemption policy for direct-to-consumer genetic health risk assessment systems.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?